FDA documents point to a broadened approval for Amarin’s Vascepa

FDA documents point to a broadened approval for Amarin’s Vascepa

STAT Plus: FDA documents point to a broadened approval for Amarin’s heart pill Vascepa

By MATTHEW HERPER AND ADAM FEUERSTEIN

AMARIN

Documents released Tuesday by reviewers at the Food and Drug Administration bode well for expanded use of Vascepa, Amarin’s fish-oil-derived heart pill.

READ MORE